Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder - Trial NCT06146049
Access comprehensive clinical trial information for NCT06146049 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Post Traumatic Stress Disorder. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Power Life Sciences Inc.
Timeline & Enrollment
N/A
Dec 01, 2024
Dec 01, 2026
Primary Outcome
Rate of patients who decide to enroll in a post traumatic stress disorder clinical research.,Number of post traumatic stress disorder study participants who remain in clinical study until completion.
Summary
Participation in post traumatic stress disorder observational study serves as a crucial
 contribution to advancing medical knowledge and refining the care provided to individuals
 facing similar health challenges.
 
 The primary objective centers on a meticulous examination of trial completion rates and
 voluntary withdrawals within this distinct patient population.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06146049
Non-Device Trial